- Home
- Publications
- Publication Search
- Publication Details
Title
Profiling Prostate Cancer Therapeutic Resistance
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 3, Pages 904
Publisher
MDPI AG
Online
2018-03-20
DOI
10.3390/ijms19030904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
- (2017) Tomasz M. Beer et al. JOURNAL OF CLINICAL ONCOLOGY
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- Navigating the evolving therapeutic landscape in advanced prostate cancer
- (2017) E. David Crawford et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Mechanisms of Therapeutic Resistance in Prostate Cancer
- (2017) Mary Nakazawa et al. Current Oncology Reports
- Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells
- (2017) Zheng Cao et al. Oncotarget
- Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
- (2016) R. S. Kelly et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Potential of MicroRNAs as Prostate Cancer Biomarkers
- (2016) Linda Fabris et al. EUROPEAN UROLOGY
- Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain
- (2016) Carmen A. Banuelos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy
- (2016) Basetti Madhu et al. Metabolomics
- Non-Smad Signaling Pathways of the TGF-β Family
- (2016) Ying E. Zhang Cold Spring Harbor Perspectives in Biology
- Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
- (2016) Steven Kregel et al. Oncotarget
- Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal Anoikis
- (2016) Roxanne Toivanen et al. Stem Cell Reports
- Innovation in metabolomics to improve personalized healthcare
- (2015) Stefano Cacciatore et al. Annals of the New York Academy of Sciences
- PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
- (2015) Elizabeth A Punnoose et al. BRITISH JOURNAL OF CANCER
- Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer
- (2015) S. K. Martin et al. CANCER RESEARCH
- Epithelial–mesenchymal transition in prostatic disease
- (2015) Seth A Broster et al. Future Oncology
- Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer
- (2015) Sebastian Meller et al. Oncotarget
- Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model
- (2015) Howard I. Scher et al. PLoS One
- AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer
- (2014) C. Priolo et al. CANCER RESEARCH
- Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)
- (2014) Dana E. Rathkopf et al. EUROPEAN UROLOGY
- Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer
- (2014) Song ChunJiao et al. IUBMB LIFE
- Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2014) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2
- (2014) Harold J. Ting et al. MOLECULAR CARCINOGENESIS
- N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy
- (2014) Sarah K. Martin et al. Molecular Oncology
- Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations
- (2014) Katarzyna A. Wójcik et al. Pharmacological Reports
- The Fringe Benefits of Cloning Cancer
- (2014) N. Kyprianou Science Translational Medicine
- Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
- (2013) K. A. Leinonen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Can Stroma Reaction Predict Cancer Lethality?
- (2013) M. R. Freeman et al. CLINICAL CANCER RESEARCH
- Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time
- (2013) Matthew R. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion
- (2013) Shengqiang Yu et al. MEDICAL ONCOLOGY
- Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism
- (2013) Salida Mirzoeva et al. MOLECULAR CARCINOGENESIS
- Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1
- (2013) Benedikta S. Haflidadóttir et al. PLoS One
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- TGF-β signaling in development and disease
- (2012) Joan Massagué FEBS LETTERS
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
- (2012) Jing Shen et al. PROSTATE
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
- (2011) Christina Scheel et al. CELL
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Pathway for the Control of Anoikis Sensitivity by E-Cadherin and Epithelial-to-Mesenchymal Transition
- (2011) S. Kumar et al. MOLECULAR AND CELLULAR BIOLOGY
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. MOLECULAR BIOLOGY OF THE CELL
- Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression
- (2011) Sally Stabler et al. PLoS One
- Application of metabolomics to prostate cancer
- (2011) Bruce J. Trock UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- New and emerging agents for the treatment of castration-resistant prostate cancer
- (2011) Celestia S. Higano et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
- (2011) Robert B. Sims VACCINE
- Roles for the type III TGF-β receptor in human cancer
- (2010) Catherine E. Gatza et al. CELLULAR SIGNALLING
- N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer
- (2010) Karin Jennbacken et al. ENDOCRINE-RELATED CANCER
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Small Cell Carcinoma of the Prostate
- (2009) Wenle Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- EMT, the cytoskeleton, and cancer cell invasion
- (2009) Mahmut Yilmaz et al. CANCER AND METASTASIS REVIEWS
- Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
- (2009) George J. Klarmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes
- (2009) R. M. Attar et al. CLINICAL CANCER RESEARCH
- Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
- (2009) D. Sarker et al. CLINICAL CANCER RESEARCH
- Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
- (2009) Sherryline Jogie-Brahim et al. ENDOCRINE REVIEWS
- Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression
- (2009) Elisabeth Jones et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
- (2009) Meng-Lei Zhu et al. FASEB JOURNAL
- Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
- (2009) Toshiro Migita et al. JNCI-Journal of the National Cancer Institute
- Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles
- (2009) Andreas Maxeiner et al. PROSTATE
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
- (2009) William P Harris et al. Nature clinical practice. Urology
- Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa
- (2008) D. R. Berthold et al. ANNALS OF ONCOLOGY
- Androgen regulation of the androgen receptor coregulators
- (2008) Alfonso Urbanucci et al. BMC CANCER
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
- (2008) E M Hurt et al. BRITISH JOURNAL OF CANCER
- Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2008) T. R. Graham et al. CANCER RESEARCH
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Stromal myofibroblasts are drivers of invasive cancer growth
- (2008) Olivier De Wever et al. INTERNATIONAL JOURNAL OF CANCER
- The role of testosterone in the pathogenesis of prostate cancer
- (2008) Takashi Imamoto et al. INTERNATIONAL JOURNAL OF UROLOGY
- The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions
- (2008) Natalie J. Serkova et al. PROSTATE
- Targeting vasculature in urologic tumors: Mechanistic and therapeutic significance
- (2007) Shinichi Sakamoto et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started